Fenofibric Acid Oral Capsule, Gastro-Resistant Pellets 135Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

Fenofibric Acid: Oral capsule, gastro-resistant pellets (135mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file DrugItem_16854.JPG
Fenofibric Acid 135mg DR Cap
Par Pharmaceuticals, formerly Anchen Pharmaceuticals
Pill Identification: Par C210 
Drug Image file DrugItem_16790.JPG
Fenofibric Acid 135mg DR Cap
Global Pharmaceuticals
Pill Identification: LOGO 135 
Drug Image file DrugItem_17845.JPG
Fenofibric Acid 135mg DR Cap
Zydus Pharmaceuticals (USA) Inc
Pill Identification: LOGO 135 
Drug Image file default-drug-image.png
Fenofibric Acid 135mg DR Cap

What is this Medicine?

FENOFIBRIC ACID (fen o FI brik AS id) can help lower blood fats and cholesterol in the blood. Diet and lifestyle changes are often used with this drug. This medicine is only for patients whose blood fats are not controlled by diet.

CVS Pharmacy Patient Statistics for Fenofibric Acid: Oral capsule, gastro-resistant pellets(135mg)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information
Select a Medication

Fenofibric Acid 135mg Delayed-Release Capsule

NDC: 103700210
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Hyperlipoproteinemia, Hypertriglyceridemia

Storage Information
Protect from moisture
Store at controlled room temperature (between 68 and 77 degrees F)
Fenofibric Acid 135mg Delayed-Release Capsule
Drug Image file DrugItem_16854.JPG
Par Pharmaceuticals, formerly Anchen Pharmaceuticals
Pill Identification: Par C210 
Shape: capsule
Color: blue,yellow

Reported Side Effects for Fenofibric Acid 135mg Delayed-Release Capsule

Infection Incidence:
<5.0%*
Severity: MILD
Onset: DELAYED
Liver Disease Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Lyell'S Syndrome Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Inability To Sleep Incidence:
<3.0%*
Severity: MILD
Onset: EARLY
No White Blood Cells Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Low Platelet Count Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Stevens-Johnson Syndrome Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Elevated Hepatic Enzymes Incidence:
0.2-13.0%*
Severity: MODERATE
Onset: DELAYED
Blood Clot Incidence:
1.0%*
Severity: SEVERE
Onset: DELAYED
Blood Clot In Lung Incidence:
1.0%*
Severity: SEVERE
Onset: DELAYED
Muscle Cramps Incidence:
1.6-3.1%*
Severity: MILD
Onset: DELAYED
Tired Incidence:
2.0-3.3%*
Severity: MILD
Onset: EARLY
Constipation Incidence:
2.1-3.3%*
Severity: MODERATE
Onset: DELAYED
Upset Stomach Incidence:
2.3-5.5%*
Severity: MILD
Onset: EARLY
Rhinitis Incidence:
2.3%*
Severity: MILD
Onset: EARLY
Vomiting Incidence:
2.3-3.5%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
2.7-4.7%*
Severity: MILD
Onset: EARLY
Sinus Infection Incidence:
2.9-3.5%*
Severity: MILD
Onset: DELAYED
High Blood Pressure Incidence:
>3.0%*
Severity: MODERATE
Onset: EARLY
Muscle Pain Incidence:
3.1-3.5%*
Severity: MILD
Onset: EARLY
Loose Stools Incidence:
3.1-3.9%*
Severity: MILD
Onset: EARLY
Headache Incidence:
3.2-13.1%*
Severity: MILD
Onset: EARLY
Sore Throat Incidence:
3.5-4.7%*
Severity: MILD
Onset: DELAYED
Joint Pain Incidence:
3.9-4.3%*
Severity: MILD
Onset: DELAYED
Lightheadedness Incidence:
4.0-4.1%*
Severity: MILD
Onset: EARLY
Back Pain Incidence:
4.1-6.3%*
Severity: MILD
Onset: DELAYED
Stomach Pain Incidence:
4.6%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Avoid - This drug is known to cause harm to infants when taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Fenofibric Acid

We want to help you stay educated about the medications you are taking. View other
patient's observations and share your own.

Be sure to consult your health care provider before taking any medications. Other
patient's comments should not be considered medical advice or health care provider
recommendations.